Smita Hiwase

Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Devendra Hiwase, Smita Hiwase, Michael Bailey et al. · Biology of Blood and Marrow Transplantation · 2007 · 87 citations · Full text

Cell Therapy, Immunology, Pathology +18

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Deepak Singhal, Li Yan A. Wee, Monika Kutyna et al. · Leukemia · 2019 · 61 citations

Hematological Malignancy, Primary Myelodysplastic Syndrome, Mutational Burden +10

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

Devendra Hiwase, Geraldine M. Bollard, Smita Hiwase et al. · Cytotherapy · 2007 · 55 citations

Hematological Malignancy, Intermediate-dose Cy, Cell Therapy +9

Cotransplantation of Placental Mesenchymal Stromal Cells Enhances Single and Double Cord Blood Engraftment in Nonobese Diabetic/Severe Combined Immune Deficient Mice

Smita Hiwase, Pamela G. Dyson, Luen Bik To et al. · Stem Cells · 2009 · 46 citations · Full text

The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma

Devendra Hiwase, Smita Hiwase, Michael Bailey et al. · Cytotherapy · 2008 · 23 citations

Hematological Malignancy, Oncology, Medicine +11